Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0FD8G
|
|||
| Former ID |
DNC009815
|
|||
| Drug Name |
2-(biphenyl-4-yl)vinylboronic acid
|
|||
| Synonyms |
352530-23-5; trans-2-(4-Biphenyl)vinylboronic acid; (2-([1,1'-Biphenyl]-4-yl)vinyl)boronic acid; (E)-(2-([1,1'-Biphenyl]-4-yl)vinyl)boronic acid; AC1O0CFW; Alkenylboronic Acid, 22; 4-Phenylstyrylboronic acid; CHEMBL453758; SCHEMBL2910475; SCHEMBL12260418; C14H13BO2; BDBM26143; DTXSID30421729; ZINC169870786; AKOS015893176; FCH5518572; AB21449; RTR-014581; KB-61854; BBV-43957496; ACM352530235; OR360465; AX8240126; [(E)-2-(4-phenylphenyl)ethenyl]boranediol; V5431; [(E)-2-(4-phenylphenyl)ethenyl]boronic acid; B-4710; I04-2357
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H13BO2
|
|||
| Canonical SMILES |
B(C=CC1=CC=C(C=C1)C2=CC=CC=C2)(O)O
|
|||
| InChI |
1S/C14H13BO2/c16-15(17)11-10-12-6-8-14(9-7-12)13-4-2-1-3-5-13/h1-11,16-17H/b11-10+
|
|||
| InChIKey |
NTRGFVQIGQYKIL-ZHACJKMWSA-N
|
|||
| CAS Number |
CAS 352530-23-5
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Carbonic anhydrase I (CA-I) | Target Info | Inhibitor | [1] |
| Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [2] | |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Nitrogen metabolism | |||
| Retrograde endocannabinoid signaling | ||||
| Panther Pathway | Anandamide degradation | |||
| Pathwhiz Pathway | Gastric Acid Production | |||
| Pathway Interaction Database | C-MYB transcription factor network | |||
| Reactome | Erythrocytes take up carbon dioxide and release oxygen | |||
| Erythrocytes take up oxygen and release carbon dioxide | ||||
| Reversible hydration of carbon dioxide | ||||
| WikiPathways | Reversible Hydration of Carbon Dioxide | |||
| Uptake of Carbon Dioxide and Release of Oxygen by Erythrocytes | ||||
| Uptake of Oxygen and Release of Carbon Dioxide by Erythrocytes | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Carbonic anhydrase inhibitors. Inhibition of the fungal beta-carbonic anhydrases from Candida albicans and Cryptococcus neoformans with boronic acids. Bioorg Med Chem Lett. 2009 May 15;19(10):2642-5. | |||
| REF 2 | Discovery of boronic acids as novel and potent inhibitors of fatty acid amide hydrolase. J Med Chem. 2008 Nov 27;51(22):7057-60. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.